These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 24969466)
21. Universal BRAF State Detection by the Pyrosequencing®-Based U-BRAF(V⁶⁰⁰) Assay. Skorokhod A Methods Mol Biol; 2015; 1315():63-82. PubMed ID: 26103892 [TBL] [Abstract][Full Text] [Related]
22. Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma. Yancovitz M; Yoon J; Mikhail M; Gai W; Shapiro RL; Berman RS; Pavlick AC; Chapman PB; Osman I; Polsky D J Mol Diagn; 2007 Apr; 9(2):178-83. PubMed ID: 17384209 [TBL] [Abstract][Full Text] [Related]
23. Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay. Bidshahri R; Attali D; Fakhfakh K; McNeil K; Karsan A; Won JR; Wolber R; Bryan J; Hughesman C; Haynes C J Mol Diagn; 2016 Mar; 18(2):190-204. PubMed ID: 26762843 [TBL] [Abstract][Full Text] [Related]
27. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies. Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101 [TBL] [Abstract][Full Text] [Related]
28. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues. Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585 [TBL] [Abstract][Full Text] [Related]
29. Identification of a novel complex BRAF mutation associated with major clinical response to vemurafenib in a patient with metastatic melanoma. Busser B; Leccia MT; Gras-Combe G; Bricault I; Templier I; Claeys A; Richard MJ; de Fraipont F; Charles J JAMA Dermatol; 2013 Dec; 149(12):1403-6. PubMed ID: 24108467 [TBL] [Abstract][Full Text] [Related]
30. A new microarray substrate for ultra-sensitive genotyping of KRAS and BRAF gene variants in colorectal cancer. Galbiati S; Damin F; Pinzani P; Mancini I; Vinci S; Chiari M; Orlando C; Cremonesi L; Ferrari M PLoS One; 2013; 8(3):e59939. PubMed ID: 23536897 [TBL] [Abstract][Full Text] [Related]
31. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas]. Zhang X; Wang Y; Gao N; Wang J Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565 [TBL] [Abstract][Full Text] [Related]
32. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA. Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762 [TBL] [Abstract][Full Text] [Related]
33. BRAF mutation detection and identification by cycling temperature capillary electrophoresis. Hinselwood DC; Abrahamsen TW; Ekstrøm PO Electrophoresis; 2005 Jun; 26(13):2553-61. PubMed ID: 15948220 [TBL] [Abstract][Full Text] [Related]
34. Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Didelot A; Le Corre D; Luscan A; Cazes A; Pallier K; Emile JF; Laurent-Puig P; Blons H Exp Mol Pathol; 2012 Jun; 92(3):275-80. PubMed ID: 22426079 [TBL] [Abstract][Full Text] [Related]
35. Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues. Schiefer AI; Parlow L; Gabler L; Mesteri I; Koperek O; von Deimling A; Streubel B; Preusser M; Lehmann A; Kellner U; Pauwels P; Lambin S; Dietel M; Hummel M; Klauschen F; Birner P; Möbs M J Mol Diagn; 2016 May; 18(3):370-377. PubMed ID: 26921540 [TBL] [Abstract][Full Text] [Related]
36. Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600). Skorokhod A; Helmbold P; Brors B; Schirmacher P; Enk A; Penzel R PLoS One; 2013; 8(3):e59221. PubMed ID: 23555633 [TBL] [Abstract][Full Text] [Related]
37. Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma. Sener E; Yildirim P; Tan A; Gokoz O; Tezel GG Pathol Res Pract; 2017 May; 213(5):522-530. PubMed ID: 28216139 [TBL] [Abstract][Full Text] [Related]
38. High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens. Cheng LY; Haydu LE; Song P; Nie J; Tetzlaff MT; Kwong LN; Gershenwald JE; Davies MA; Zhang DY Sci Rep; 2021 Apr; 11(1):9043. PubMed ID: 33907234 [TBL] [Abstract][Full Text] [Related]
39. Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. Spittle C; Ward MR; Nathanson KL; Gimotty PA; Rappaport E; Brose MS; Medina A; Letrero R; Herlyn M; Edwards RH J Mol Diagn; 2007 Sep; 9(4):464-71. PubMed ID: 17690212 [TBL] [Abstract][Full Text] [Related]
40. A HRM assay for identification of low level BRAF V600E and V600K mutations using the CADMA principle in FFPE specimens. Huebner C; Weber R; Lloydd R Pathology; 2017 Dec; 49(7):776-783. PubMed ID: 29100713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]